XML 39 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes
12 Months Ended
Dec. 27, 2020
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Reconciliations between the effective tax rate on income from continuing operations before income taxes and the federal statutory rate are presented below.
 December 27, 2020December 29, 2019December 30, 2018
(In thousands)Amount% of
Pre-tax
Amount% of
Pre-tax
Amount% of
Pre-tax
Tax at federal statutory rate$24,241 21.0 $34,537 21.0 $36,979 21.0 
State and local taxes, net3,873 3.4 5,303 3.2 12,335 7.0 
Effect of enacted changes in tax laws  — — (1,872)(1.0)
(Decrease)/increase in uncertain tax positions(2,509)(2.2)(2,427)(1.5)2,288 1.3 
(Gain)/loss on company-owned life insurance(635)(0.6)(1,662)(1.0)449 0.2 
Nondeductible expense800 0.7 1,938 1.2 1,808 1.0 
Nondeductible executive compensation1,271 1.1 (355)(0.2)2,135 1.2 
Stock-based awards benefit(7,251)(6.3)(6,184)(3.8)(1,795)(1.0)
Deduction for foreign-derived intangible income(686)(0.6)(2,625)(1.6)— — 
Research and experimentation credit(3,892)(3.4)(5,672)(3.4)— — 
Other, net(617)(0.5)1,641 1.0 (3,696)(2.1)
Income tax expense$14,595 12.6 $24,494 14.9 $48,631 27.6 
The components of income tax expense as shown in our Consolidated Statements of Operations were as follows:
(In thousands)December 27,
2020
December 29,
2019
December 30,
2018
Current tax expense/(benefit)
Federal$21,414 $16,283 $31,719 
Foreign905 823 705 
State and local7,453 3,146 10,172 
Total current tax expense29,772 20,252 42,596 
Deferred tax expense/(benefit)
Federal(9,249)5,588 913 
State and local(5,928)(1,346)5,122 
Total deferred tax expense(15,177)4,242 6,035 
Income tax expense$14,595 $24,494 $48,631 
State tax operating loss carryforwards totaled $1.3 million as of December 27, 2020, and $1.6 million as of December 29, 2019. Such loss carryforwards expire in accordance with provisions of applicable tax laws and have remaining lives up to 17 years.
The components of the net deferred tax assets and liabilities recognized in our Consolidated Balance Sheets were as follows:
(In thousands)December 27,
2020
December 29,
2019
Deferred tax assets
Retirement, postemployment and deferred compensation plans$103,433 $113,306 
Accruals for other employee benefits, compensation, insurance and other25,899 25,543 
Net operating losses1,510 1,289 
Operating lease liabilities16,648 16,746 
Other32,664 27,042 
Gross deferred tax assets$180,154 $183,926 
Valuation allowance(293)— 
Net deferred tax assets$179,861 $183,926 
Deferred tax liabilities
Property, plant and equipment$41,832 $39,494 
Intangible assets7,652 7,596 
Operating lease right-of-use assets14,196 14,309 
Other16,663 7,298 
Gross deferred tax liabilities$80,343 $68,697 
Net deferred tax asset$99,518 $115,229 
We assess whether a valuation allowance should be established against deferred tax assets based on the consideration of both positive and negative evidence using a “more likely than not” standard. In making such judgments, significant weight is given to evidence that can be objectively verified. We evaluated our deferred tax assets for recoverability using a consistent approach that considers our three-year historical cumulative income/(loss), including an assessment of the degree to which any such losses were due to items that are unusual in nature (i.e., impairments of nondeductible goodwill and intangible assets).
We had a valuation allowance totaling $0.3 million as of December 27, 2020, for deferred tax assets primarily associated with net operating losses of a U.S. subsidiary, as we determined these assets were not realizable on a more-likely-than-not basis. We had no valuation allowance as of December 29, 2019.
We had an income tax receivable of $3.3 million as of December 27, 2020, compared with an income tax receivable of $12.6 million as of December 29, 2019.
Income tax benefits related to the exercise or vesting of equity awards reduced current taxes payable by $13.1 million, $11.9 million and $4.8 million in 2020, 2019 and 2018, respectively.
As of December 27, 2020, and December 29, 2019, Accumulated other comprehensive loss, net of income taxes in our Consolidated Balance Sheets and for the years then ended in our Consolidated Statements of Changes in Stockholders’ Equity was net of deferred tax assets of approximately $160 million and $188 million, respectively.
A reconciliation of unrecognized tax benefits is as follows:
(In thousands)December 27,
2020
December 29,
2019
December 30,
2018
Balance at beginning of year$10,309 $11,629 $17,086 
Gross additions to tax positions taken during the current year1,130 1,184 680 
Gross additions to tax positions taken during the prior year133 711 3,019 
Gross reductions to tax positions taken during the prior year(93)(76)(8,607)
Reductions from settlements with taxing authorities(3,814)(2,637)— 
Reductions from lapse of applicable statutes of limitations(928)(502)(549)
Balance at end of year$6,737 $10,309 $11,629 
The total amount of unrecognized tax benefits that would, if recognized, affect the effective income tax rate was approximately $6 million and $9 million as of December 27, 2020, and December 29, 2019, respectively.
In 2020 and 2019, we recorded a $5.4 million and a $3.8 million income tax benefit, respectively, due to a reduction in the Company’s reserve for uncertain tax positions.
We also recognize accrued interest expense and penalties related to the unrecognized tax benefits within income tax expense or benefit. The total amount of accrued interest and penalties was approximately $1 million and $2 million as of December 27, 2020, and December 29, 2019, respectively. The total amount of accrued interest and penalties was a net benefit of $0.7 million in 2020, a net benefit of $0.6 million in 2019 and a net benefit of $0.7 million in 2018.
With few exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years prior to 2013. Management believes that our accrual for tax liabilities is adequate for all open audit years. This assessment relies on estimates and assumptions and may involve a series of complex judgments about future events.
It is reasonably possible that certain income tax examinations may be concluded, or statutes of limitation may lapse, during the next 12 months, which could result in a decrease in unrecognized tax benefits of $4.6 million that would, if recognized, impact the effective tax rate.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") was signed into law. The tax provisions in the CARES Act did not have a material impact on our 2020 Consolidated Financial Statements.